About High Care Pharma Private Limited
Data last updated:
High Care Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2015PTC097738. Its GSTIN is 37AADCH5633E1ZQ (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Mustafa Shaik and John Shaheed Shaik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 11 – 5 – 462 Road No 14 Venkateswara Colony Saroor Nagar, Hyderabad, Telangana, India – 500035.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.65 Lakh, a decline of 86% compared to the previous year. For the same year it recorded a net profit of ₹71,143 (net margin 19.5%) and EBITDA of ₹86,401 (EBITDA margin 23.7%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years and 42% over five years.
The company is associated with 1 brand: HIGH CARE pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website highcarepharma.com.
Company details
Contact details
High Care Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is highcarepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address11 – 5 – 462 Road No 14 Venkateswara Colony Saroor Nagar, Hyderabad, Telangana, India – 500035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of High Care Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
High Care Pharma operates one associated brand: HIGH CARE pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products including tablets, capsules, syrup, and semi-solids. | highcarepharma.com |
Business activity
The main business activity of High Care Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of High Care Pharma Private Limited, buy the company report.
Financials of High Care Pharma Private Limited
FY 2025 filings availableHigh Care Pharma Private Limited reported revenue of ₹3.65 Lakh (down 86% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 42% over five years, including a 86% fall in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86,401 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71,143 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.7% | ||||
| Net Profit Margin | 19.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of High Care Pharma Private Limited, buy the company report.
Board of directors of High Care Pharma Private Limited
High Care Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mustafa Shaik | Director | 24 Aug 2021 | 5 Years 2 Months | Current |
| John Shaheed Shaik | Director | 16 Sep 2015 | 11 Years 1 Months | Current |
| Kumar Hari Kiran Karanam | Director | 23 Feb 2015 | 11 Years 8 Months | Current |
Peer comparison
High Care Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fidelis Meditech Private Limited | ₹3.74 Lakh (FY 2022) | -5.0% | Ambala Cantt, Haryana, India | |||
| Nedumaan Pharmaceutical Private Limited | ₹3.71 Lakh (FY 2022) | 1050.0% | Naubasta Kanpur, Uttar Pradesh, India | |||
| Alberta Remedies Private Limited | ₹3.71 Lakh (FY 2023) | -44.0% | New Delhi, Delhi, India | |||
| Vaxxon Pharmaceuticals Private Limited | ₹3.67 Lakh (FY 2024) | Noida, Uttar Pradesh, India | ||||
| High Care Pharma Private Limitedthis company | ₹3.65 Lakh (FY 2025) | ₹71,143 | 19.5% | -86.0% | Hyderabad, Telangana, India | |
| Prayan Pharma Private Limited | ₹3.64 Lakh (FY 2022) | 25.0% | Delhi, India | |||
| Biolan Healthcare Private Limited | ₹3.64 Lakh (FY 2025) | Rewa, Madhya Pradesh, India | ||||
| Alef Pharmaceuticals Private Limited | ₹3.63 Lakh (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of High Care Pharma Private Limited, buy the company report.
Auditor
High Care Pharma Private Limited is audited by M DIVAKARA SARMA AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M DIVAKARA SARMA AND CO | FY 2023 | 228570 |
Shareholding
The shareholding of High Care Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of High Care Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving High Care Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for High Care Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
High Care Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCH5633E1ZQ | Andhra Pradesh | Active | 11 Oct 2019 |
To see the full GST registrations and return filing status of High Care Pharma Private Limited, buy the company report.
Recent activity
High Care Pharma Private Limited has 6 board changes on record since 2015: 3 appointments and 3 cessations. The latest: Mustafa Shaik was appointed as Director on 24 Aug 2021.
Frequently asked questions
High Care Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 February 2015 (11+ years old) and is registered under CIN U24233TG2015PTC097738.
High Care Pharma has 3 current directors:
- Mustafa Shaik - Director
- John Shaheed Shaik - Director
- Kumar Hari Kiran Karanam - Director
The latest financial statements of High Care Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of High Care Pharma is 37AADCH5633E1ZQ, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of High Care Pharma is U24233TG2015PTC097738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
High Care Pharma was incorporated on 23 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of High Care Pharma by revenue are Fidelis Meditech Private Limited, Nedumaan Pharmaceutical Private Limited, Alberta Remedies Private Limited, Vaxxon Pharmaceuticals Private Limited, Prayan Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Mustafa Shaik was appointed as Director on 24 Aug 2021. John Shaheed Shaik ceased to be Additional Director on 30 Sep 2016. Ameeruddin Syed ceased to be Director on 11 Apr 2016. High Care Pharma has 6 board changes on record in total.
High Care Pharma can be reached through the website highcarepharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of High Care Pharma is at 11 – 5 – 462 Road No 14 Venkateswara Colony Saroor Nagar, Hyderabad, Telangana, India – 500035.
High Care Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.